New cancer drug begins first human safety tests
NCT ID NCT06933524
Summary
This early-stage trial aims to test the safety of an experimental drug called ATB-320 in adults with advanced solid tumors that have spread or progressed despite standard treatments. The study will enroll 24 participants to determine the highest safe dose and identify any serious side effects. This is a first-in-human study, so researchers are primarily focused on safety rather than effectiveness at this stage.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.